advisorsecurities master

TOVXTheriva Biologics, Inc.

CSNYSE American, LLC (XASE)·USD

Identity

Security key
22667
Ticker
TOVX
Type
CSCommon Stock
Exchange
NYSE American, LLC(XASE)
Venue group
NYSE
Operating MIC
XNYS
Market
stocks
Locale
us
Currency
USD
Listed
1993-04-05
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
TOVX

Detail

Enriched 2026-08-14 20:47

Market cap
$11,014,240.32
Shares outstanding (class)
45,892,668
Shares outstanding (weighted)
45,892,668
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
16
Location
ROCKVILLE, MD
Description

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data